Subtherapeutic

Subtherapeutic refers to a drug dose or plasma concentration that is below the level needed to achieve the desired therapeutic effect. In pharmacology and clinical practice, subtherapeutic levels can result from too small a dose, poor adherence, impaired absorption, rapid metabolism, or drug interactions that reduce bioavailability. When concentrations remain below the therapeutic range, treatments may fail to control symptoms or eradicate disease, and inappropriate exposure may promote resistance, especially with antimicrobial agents.

In veterinary medicine and agriculture, subtherapeutic antibiotic doses have historically been added to animal feeds to promote growth and feed efficiency. Growing concerns about antimicrobial resistance and potential transfer of resistance genes to humans have led to regulatory reforms in many countries, including bans or phaseouts of growth-promoting subtherapeutic antibiotic use and tighter oversight of drug additives.

Clinical management strategies aim to avoid subtherapeutic exposure by appropriate dosing, adherence, and, when needed, therapeutic drug monitoring to confirm levels remain within the therapeutic window. Pharmacokinetic/pharmacodynamic principles are used to tailor regimens and to minimize the risk of treatment failure and resistance.

Subtherapeutic contrasts with therapeutic (within the effective range) and supratherapeutic (above the safe, effective range). The term is used primarily in discussions of dosing, pharmacokinetics, and antimicrobial stewardship.